BioSpace News Archive

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB) (Headquarters: Cambridge, Massachusetts, United States, CEO: Michel Vounatsos, “Biogen”) announced detailed results from the Phase II study (Study 201) with BAN2401, an anti-amyloid beta (Aβ) protofibril antibody

Clinical data presented at the 2018 annual meeting of the American Orthopaedic Foot & Ankle Society (AOFAS)

Over the last year, Amatheon Animal Health has encountered recent growth challenges of which our customer environment was impacted.

Edwards Lifesciences Corporation commented on the U.S. Centers for Medicare and Medicaid Services’ (CMS) advisory panel regarding evidence pertaining to procedural volume requirements for transcatheter aortic valve replacement (TAVR) programs

Audacious Inquiry announced three new hires as the company continues to add depth, experience and leadership throughout the organization.

Gilead Sciences, Inc. announced that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the third quarter of 2018.

Senseonics Holdings, Inc. announced that it plans to release its second quarter 2018 financial results after market close on Wednesday, August 8, 2018.

Encompass Health Corp. reported its results of operations for the second quarter ended June 30, 2018.

Federman & Sherwood announces that on July 19, 2018, a class action lawsuit was filed in the United States District Court for the Southern District of California against Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD).

Dr. Chris Yu, Chief Executive Officer of international life sciences corporation, Anpac Bio-Medical Science Company, announced the company’s valuation leapt nearly 30%